Alcoholic liver disease epidemiology and demographics
|
Alcoholic liver disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alcoholic liver disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Alcoholic liver disease epidemiology and demographics |
|
FDA on Alcoholic liver disease epidemiology and demographics |
|
CDC on Alcoholic liver disease epidemiology and demographics |
|
Alcoholic liver disease epidemiology and demographics in the news |
|
Blogs on Alcoholic liver disease epidemiology and demographics |
|
Risk calculators and risk factors for Alcoholic liver disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- According to National Institute of Alcohol Abuse and Alcoholism the incidence of alcoholic steatosis is approximately 20,000 per 100,000 alcoholics and heavy drinkers.[1]
Prevalence
- The prevalence of alcoholic liver disease is estimated to be 604 per 100,000 individuals within the age group of 25 to 44 years.[2][3]
- The prevalence of alcoholic liver disease is estimated to be 948 per 100,000 individuals within the age group of 45 to 64 years.[2][4][5]
Mortality rate
- The 5-year mortality rate in patients suffering from well compensated alcoholic cirrhosis is approximately 58000 per 100,000 individuals.[6]
- The 28-day mortality rate of patients suffering from alcoholic hepatitis ranges from a low of 20000 per 100,000 individuals to a high of 30000 per 100,000 individuals.[7]
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Mann RE, Smart RG, Govoni R (2003). "The epidemiology of alcoholic liver disease". Alcohol Res Health. 27 (3): 209–19. PMID 15535449.
- ↑ 2.0 2.1 Mandayam S, Jamal MM, Morgan TR (2004). "Epidemiology of alcoholic liver disease". Semin. Liver Dis. 24 (3): 217–32. doi:10.1055/s-2004-832936. PMID 15349801.
- ↑ Adams WL, Yuan Z, Barboriak JJ, Rimm AA (1993). "Alcohol-related hospitalizations of elderly people. Prevalence and geographic variation in the United States". JAMA. 270 (10): 1222–5. PMID 8355385.
- ↑ Adang RP, Wensing JW, Stockbrügger RW (1998). "Alcohol consumption and alcohol-related liver disease in The Netherlands". Scand. J. Gastroenterol. Suppl. 225: 70–4. PMID 9515756.
- ↑ Singh GK, Hoyert DL (2000). "Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption". Hum. Biol. 72 (5): 801–20. PMID 11126726.
- ↑ Borowsky SA, Strome S, Lott E (1981). "Continued heavy drinking and survival in alcoholic cirrhotics". Gastroenterology. 80 (6): 1405–9. PMID 6971772.
- ↑ Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI (1978). "Corticosteroid therapy of alcoholic hepatitis". Gastroenterology. 75 (2): 193–9. PMID 352788.